Quillaja

Condiciones de salud que Quillaja puede ayudar a apoyar.

• HipocondríaCientífico

  Quillaja saponin extract has demonstrated higher free radical scavenging capacity than lecithin in an oxygen radical absorbance capacity (ORAC) assay and significantly reduced lipid peroxidation markers in nanoemulsion and animal models. These findings are from in vitro and animal studies.

• Válvula IleocecalCientífico

  A human clinical study found that a blend of Quillaja saponaria and Yucca schidigera extracts reduced total and LDL cholesterol in hypercholesterolemic patients over four weeks. Mechanistic in vitro studies confirm that Quillaja dry saponin extract reduces cholesterol bioaccessibility by precipitating cholesterol and displacing it from dietary mixed micelles.

• ApendicitisCientífico

  Quillaja saponin extract has demonstrated dose-dependent anti-inflammatory activity in a carrageenan-induced paw edema murine model. Quillaic acid, the primary aglycone, exhibits strong topical anti-inflammatory activity in mouse models. Evidence is preclinical; no human inflammation trials exist.

• JuanetesCientífico

  Quillaja saponins have demonstrated cholesterol-lowering effects in a human clinical study, providing indirect cardiovascular benefit. In vitro and animal data further support reduction of cholesterol bioaccessibility and triglycerides. No direct cardiovascular outcome trials (e.g., MACE, arterial stiffness) exist for Quillaja.

• DebilidadCientífico

  In a rat model of iron-induced hepatotoxicity, Quillaja bark saponin significantly reduced elevated triglyceride (TG) levels, bringing them to 54% of the hepatotoxicity control. In vitro studies also suggest saponins interfere with intestinal lipid solubilization broadly, including triglyceride lipolysis products.

• Sarpullido por pañalCientífico

  Quillaja-derived QS-21 has been used as an immune adjuvant in over 80 clinical trials involving approximately 15,000 patients, enhancing both antibody and T-cell responses to vaccine antigens. Quillaja extracts also demonstrate direct antiviral activity in vitro and in vivo against multiple viruses including rotavirus, HSV-1, HIV, and varicella zoster.

• AlcalosisTradicional

  Quillaja bark has a long history of traditional use in Chilean and Andean folk medicine for respiratory complaints, including cough and bronchitis. The saponin content is thought to stimulate the production of more watery mucus in the airways, facilitating expectoration. No controlled human clinical trials have confirmed this effect specifically for bronchial health.

• EndometriosisTradicional

  Oral Quillaja bark preparations have been used in traditional South American medicine specifically for bronchitis and cough for centuries. The saponins are thought to act as expectorants. No controlled human clinical trials support efficacy for bronchitis.

• Pie de atletaTradicional

  Topical application of Quillaja bark extract or powder to the scalp to relieve itchiness and dandruff is one of the two most explicitly documented traditional uses of this plant. Drugs.com specifically cites this traditional use. No clinical trials have confirmed efficacy for dandruff.

• FatigaTradicional

  Quillaja saponins exhibit documented in vitro antifungal activity against multiple fungal species, and the bark has traditional topical use for scalp conditions associated with fungal overgrowth. The antifungal mechanism involves disruption of fungal cell membranes via cholesterol complexation. Evidence is preclinical and traditional, not from human skin trials.

• Quimioterapia (reducción de efectos secundarios)Tradicional

  Quillaja bark's traditional use by Andean peoples for chest complaints encompasses general lung support via expectorant action. The saponins promote more fluid airway secretions to aid clearance. No clinical trials address lung function or lung health outcomes.

• Manos y Pies FríosTradicional

  Traditional Andean and Chilean folk use of Quillaja bark centers on its expectorant action, attributed to the ability of its saponins to promote a more fluid mucus in the airways. This facilitates clearance of phlegm through coughing. The mechanism is plausible given the surfactant nature of the saponins, but no clinical trials have validated this specific endpoint.

• Tos (general)Tradicional

  Traditional use of Quillaja bark in South American ethnomedicine for cough, chest congestion, and respiratory complaints provides an indirect basis for its association with seasonal respiratory support. No specific clinical data address seasonal conditions.

• Enfermedad de CushingTradicional

  Quillaja has been used in Chilean folk medicine as an oral remedy for throat and upper respiratory complaints. The foaming, demulcent-like properties of its saponins provide a rationale for soothing throat irritation. No clinical trials support this use specifically.

• DefensividadTradicional

  Quillaja saponaria has a long record of traditional use by Andean peoples for various chest and upper respiratory problems. The saponin-rich bark is used as an expectorant and cough remedy. Evidence remains traditional with no controlled clinical trials.

Sistemas corporales que Quillaja puede ayudar a apoyar.

• No hay sistemas corporales disponibles.